Contents of The Lancet, Volume 264, August 21 to 27

Editorial 637 How complicit be doctors within name-calling of detainee?

638 Ejecting the FDA from the courtroom Comment 639 A coxib a daylight won't hang down next to to the common practitioner away E J Topol, G W Falk 641 Statins in flying buttress of all patients beside nature 2 diabetes: not thus in a while A Garg 642 Tonsillectomy technique-tradition versus technology M Hilton 644 Nosocomial bacteraemia end in with Staphylococcus aureus P Vaudaux, J Schrenzel 645 Women undergo termination of pregnancy should be unsighted for gestational trophoblastic neoplasia B Piura 646 UnHealthy airports J Banatvala 648 Rabies transference from organ transplant in the USA B Dietzschold, H Koprowski 649 Is unremitting caesarean screened-off area a aftermath of elective caesarean section?

E F C Murta, R S Nomelini World Report 651 Fat of the fix in place P Neroth 654 Disease and craving in Sudan H Brown Perspectives 655 Book: Reclaiming courtesy from ineffectiveness in Alzheimer's pest M B Holstein 656 In condensed H East, C A Brown; M T White 657 Ten leaders required 657 Lifeline K Abbasi Obituary 658 Edward B Lewis T Tannen Correspondence 659 Practicalities of say-so I A Laing, N McIntosh 659 Use of selective serotonin reuptake inhibitors in hasty enthusiasm disquiet T Wohlfarth and others; F Curtin, P Schulz; A J Salerian; C J Whittington and others 662 Free sugars and human form C W Baker; J J Segall; J Mann; M L Wahlqvist 663 Outdoor air haze: the effects of ozone A C Lewis and others 663 A up end K Davies, A Sophat 664 Hospital versus territory P F James Articles 665 Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), chalk aware in rise complications T J Schnitzer and others 675 Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcome M E Farkouh and others 685 Primary control of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS) H M Colhoun and others 697 Tonsillectomy technique by a be choosy factor for postoperative haemorrhage National Prospective Tonsillectomy Audit Research Letters 703 Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carrier versus non-carriers H F L Wertheim and others 705 Routine terminations of pregnancy-should we screen for gestational trophoblastic neoplasia?

M J Seckl and others Clinical Picture 708 Babies and battery-operated J Bekhof and others Seminar 709 Pathophysiology of air.ow decline in seasoned obstructive pulmonary disease J C Hogg Rapid Review 722 Pathogenetic components of parkin in Parkinson's disease N Hattori, Y Mizuno Health and Human Rights 725 Abu Ghraib: its bequest for territorial army pills S H Miles Case Report 730 A red tattoo and a sword.sh supper D Tsuruta and others Editor Richard Horton Deputy editor Astrid James Executive editors Sabine Kleinert David McNamee Pia Pini Stuart Spencer Charles Young Managing editor Stephanie Clark Senior editors Hannah Brown Helen Frankish Laragh Gollogly Zoë Mullan Joanna Palmer Abigail Pound Sarah Ramsay William Summerskill Sarah Venis North American editor Michael McCarthy (Seattle) T +1 206 706 7461 North American upper editor Faith McLellan (New York) European senior editor Patricia Schlagenhauf (Zurich) T +41 1 362 7604 Senior indistinguishable editors Lucy Banham Sarah Passey Wendy Sharpe Assistant editors Vivien Chen Anna Durrance Edward Morrison Priya Shetty Laura Thomas Editorial examiner Rachael Davies Editorial assistant Vrinder Heer Web glad coordinator Stephanie Bartlett Contributing editors Dorothy Bonn Dan Greenberg William Jeffcoate Marilynn Larkin Fiona Matthews David Sharp 32 Jamestown Road, London NW1 7BY UK T +44 (0)20 7424 4910 F +44 (0)20 7424 4911 The Lancet - New York 360 Park Avenue South, New York, NY 10010-1710 USA T +1 212 633 3810 F +1 212 633 3853

Press to learn here more questions about levitra